NILOTINIB Zentiva caps 200 mg 28 pce

7680698460039 CH-69846 L01EA03 07.16.1.

Active substances:

No images available

Details

Product number
6984603
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
nilotinibum 200 mg, lactosum monohydricum 173.8 mg, crospovidonum, polysorbatum 80, magnesii aluminometasilicas, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (flavum), aqua purificata, Drucktinte: lacca, natrii hydroxidum, E 171, povidonum K 17, E 129, pro capsula.

Articles (1)

Nilotinib Zentiva 200 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/04/2026
Patient information leaflet
Français
01/04/2026
Patient information leaflet
Italien
01/04/2026
Professional SmPC
Allemand
01/04/2026
Professional SmPC
Français
01/04/2026
Professional SmPC
Italien
01/04/2026

Detailed composition

Substance Quantity Type Category
nilotinibum
200.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
173.8 MG Substance HBESI
crospovidonum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
magnesii aluminometasilicas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
E 171
- Substance FNIDK
povidonum K 17
- Substance HNIDK
E 129
- Substance HBESI

Reimbursement information

Public price
CHF 483.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
69846
Drug name
Nilotinib Zentiva, Hartkapseln
Galenic form
KAHA
ATC Code
L01EA03
Authorization status
Z
Dispensation category
A
First authorization
20/11/2025
Authorization expiration date
19/11/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum, Tyrosin-Kinase-Hemmer zur Behandlung der chronischen myeloischen Leukämie

Packaging details

Description (FR)
NILOTINIB Zentiva caps 200 mg 28 pce
Description (DE)
NILOTINIB Zentiva Kaps 200 mg 28 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Original drug

Tasigna, Kapseln
CHF 926.60
View original

Other packaging sizes

NILOTINIB Zentiva caps 50 mg 120 pce
120 KAP
View
NILOTINIB Zentiva caps 150 mg 112 pce
112 KAP
View
NILOTINIB Zentiva caps 200 mg 112 pce
112 KAP
View
Buy us a coffee Explore the data